Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · Operating Cash Flow (Statement)

Latest reported-$2.66Mperiod endingJun 30, 2026

CANF Quarterly Cash from Operations (-$671.96K → -$2.66M)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

CANF operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2026	-2,657,000
Mar 31, 2026	-2,657,000
Dec 31, 2025	-2,098,500
Sep 30, 2025	-2,098,500
Jun 30, 2025	-2,376,000
Mar 31, 2025	-2,376,000
Dec 31, 2024	-1,800,500
Sep 30, 2024	-1,800,500
Jun 30, 2024	-2,017,999
Mar 31, 2024	-2,017,999
Dec 31, 2023	0
Sep 30, 2023	-95,000
Jun 30, 2023	95,000
Mar 31, 2023	0
Dec 31, 2022	263,000
Sep 30, 2022	-135,000
Jun 30, 2022	135,000
Mar 31, 2022	0
Dec 31, 2021	0
Sep 30, 2021	0
Jun 30, 2021	0
Mar 31, 2021	0
Dec 31, 2020	0
Sep 30, 2020	0
Jun 30, 2020	0
Mar 31, 2020	0
Dec 31, 2019	0
Sep 30, 2019	0
Jun 30, 2019	0
Mar 31, 2019	0
Dec 31, 2018	0
Sep 30, 2018	0
Jun 30, 2018	0
Mar 31, 2018	0
Dec 31, 2017	0
Sep 30, 2017	0
Jun 30, 2017	0
Mar 31, 2017	0
Dec 31, 2016	0
Sep 30, 2016	0
Jun 30, 2016	0
Mar 31, 2016	0
Dec 31, 2015	0
Sep 30, 2015	0
Jun 30, 2015	0
Mar 31, 2015	0
Dec 31, 2014	0
Sep 30, 2014	0
Jun 30, 2014	0
Mar 31, 2014	0
Dec 31, 2013	-2,807,975
Sep 30, 2013	-1,592,213
Jun 30, 2013	-1,643,896
Mar 31, 2013	-2,489,572
Dec 31, 2012	-1,031,475
Sep 30, 2012	-794,106
Jun 30, 2012	-1,400,413
Mar 31, 2012	-1,199,779
Dec 31, 2011	-1,192,450
Sep 30, 2011	-817,022
Jun 30, 2011	-1,623,271
Mar 31, 2011	-1,856,934
Dec 31, 2010	-671,958